Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Debt / NOTE 3.750% 2/0
-
Market price (% of par)
-
125.36%
-
Total 13F principal
-
$335,633,000
-
Principal change
-
-$258,000
-
Total reported market value
-
$421,453,059
-
Number of holders
-
24
-
Value change
-
+$1,958,066
-
Number of buys
-
10
-
Number of sells
-
13
Institutional Holders of NOVAVAX INC - NOTE 3.750% 2/0 as of Q4 2020
As of 31 Dec 2020,
NOVAVAX INC - NOTE 3.750% 2/0 was held by
24 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$335,633,000
in principal (par value) of the bond.
The largest 10 bondholders included
Davidson Kempner Capital Management LP, Whitebox Advisors LLC, Graham Capital Management, L.P., PFM Health Sciences, LP, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), LAZARD ASSET MANAGEMENT LLC, FMR LLC, CITADEL ADVISORS LLC, AMERIPRISE FINANCIAL INC, and UBS ASSET MANAGEMENT AMERICAS INC.
This page lists
24
institutional bondholders reporting positions
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.